Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2005
12/21/2005EP1605754A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds
12/21/2005EP1605753A2 Production of n-aryl-2-lactam and n-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005CN1711239A Novel biaromatic compounds which activate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/21/2005CN1711081A Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
12/21/2005CN1709870A Optical-purity N',N'-dibasic prolyl hydrazine compound, and its preparing method and use
12/21/2005CN1232518C Bi-heterocyclic compounds with antitumour and chemosensitising activity
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/20/2005US6977303 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/20/2005CA2171275C Stilbene derivatives and pharmaceutical compositions containing them
12/15/2005WO2005118538A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
12/15/2005WO2005118537A2 Arylpiperazine derivatives as adrenergic receptor antagonists
12/15/2005WO2005118536A1 Process for the preparation of atorvastatin
12/15/2005WO2005118535A1 Substituted pyrrolidine-2-ones
12/15/2005WO2005118534A1 Cis pyrrolidinyl derivatives and their uses
12/15/2005WO2005118533A1 Trans pyrrolidinyl derivatives and their pharmaceutical use
12/15/2005WO2005118532A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
12/15/2005WO2005118531A1 Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake
12/15/2005WO2005118525A1 Synthesis of amino-alkoxy-heptanoic alkyl ester
12/15/2005WO2005117865A1 Naphthaline derivatives useful as histamine-3-receptor ligands
12/15/2005WO2005087751A3 Substituted hydroxyethylamine aspartyl protease inhibitors
12/15/2005WO2005074598A3 Nitroxyl progenitor compounds and methods of use
12/15/2005WO2005044195A3 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/15/2005US20050277688 Napadisylate salt formation of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide in an aqueous isopropanol or ethanol solution; combined with a beta 2 adrenergic receptor agonist or a steroidal anti-inflammatory agent; COPD, asthma; muscarinic receptor antagonists, bronchodilators
12/15/2005US20050277683 Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
12/15/2005CA2568836A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds
12/15/2005CA2568773A1 Cis pyrrolidinyl derivatives and their uses
12/15/2005CA2568769A1 Trans pyrrolidinyl derivatives and their pharmaceutical use
12/15/2005CA2567914A1 Synthesis of amino-alkoxy-heptanoic alkyl ester
12/15/2005CA2565689A1 Substituted pyrrolidine-2-ones
12/15/2005CA2561858A1 Arylsulfonamides and uses related thereto
12/14/2005EP1604979A1 2-oxo-1-pyrrolidine derivative and its pharmaceutical uses
12/14/2005EP1604978A1 Trans pyrrolidinyl derivatives and their pharmaceutical uses
12/14/2005EP1604977A1 CIS pyrrolidinyl derivatives and their uses
12/14/2005EP1604662A1 1-[(3R)-Amino-4-(2-fluoro-phenyl)-butyl]-pyrrolidine-(2R)-carboxylic acid benzyl amine derivatives and related compounds as dipeptidyl peptidase IV (DPP-IV) inhibitors for the treatment of type 2 diabetes mellitus
12/14/2005EP1603911A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
12/14/2005EP1603902A1 New heterocyclic compounds, a process for their preparation and their use as dyes and pigments
12/14/2005EP1603875A1 New process for preparing 4-aminomethyl-3-alkoxyiminopyrrolidine methanesulfonate
12/14/2005EP1603874A2 G-lactam derivatives as prostaglandin agonists
12/14/2005EP1603562A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
12/14/2005EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/14/2005EP1066258B1 Aryl phenyl substituted cyclic ketoenols
12/14/2005CN1708489A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
12/14/2005CN1708480A Carotenoid analogs for the inhibition and amelioration of disease
12/14/2005CN1708478A P-(sulfonyl)-aryl and heteroaryls amines
12/14/2005CN1708476A Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
12/14/2005CN1706825A New synthesis process of sultopride hydrochloride
12/14/2005CN1706824A Compound as CCR5 agonist
12/14/2005CN1231492C Solution phase synthesis of oligonucleotides
12/13/2005US6974825 piperidines or pyrroles with an amido- or sulfonamidophenylamino group; reductive amination of a piperidone with a substituted arylamine then further arylation; ligand for the delta opiod receptor; less side effects than current mu agonists; oral
12/13/2005CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds
12/08/2005WO2005116029A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005WO2005116014A1 Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
12/08/2005WO2005115980A1 Salt forms of atorvastatin
12/08/2005WO2005115979A1 Anti-tubulin acting arylpyrrol, arylfulran and arylthiopene derivatives, method for the preparation and use thereof as an antimitotic
12/08/2005WO2005115978A1 Process for the preparation of optically pure 4-hydroxy-2-oxo-1-pyrrolidine acetamide
12/08/2005WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists
12/08/2005WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005WO2005115975A1 Arylalkylamines and process for production thereof
12/08/2005WO2005115972A1 Therapeutic compounds
12/08/2005WO2005115361A2 Androgen receptor modulators and method of treating disease using the same
12/08/2005WO2005090294A3 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES
12/08/2005WO2005087724A3 Sulphonylpyrroles as hdac inhibitors
12/08/2005WO2005082350A8 Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation
12/08/2005WO2005034940A3 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
12/08/2005US20050272815 Compounds and compositions for delivering active agents
12/08/2005US20050272803 Phosphodiesterase 4 inhibitors
12/08/2005US20050272801 Isoprenoid pathway inhibitors for stimulating cartilage growth
12/08/2005US20050272780 Small molecule inhibitors of rotamase enzyme activity
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272718 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes
12/08/2005US20050272710 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals
12/08/2005US20050272665 Synthesis of alpha-amino-beta-alkoxy-carboxylic acid esters
12/08/2005CA2568046A1 3-amino-2-phenylpyrrolidine derivatives
12/08/2005CA2567931A1 Salt forms of atorvastatin
12/08/2005CA2566942A1 Androgen receptor modulators and method of treating disease using the same
12/08/2005CA2566038A1 Anti-tubulin acting arylpyrrol, arylfulran and arylthiopene derivatives, method for the preparation and use thereof as an antimitotic
12/08/2005CA2565066A1 Therapeutic compounds
12/08/2005CA2564884A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1601650A2 Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1000620B1 Lp(a)-LOWERING AGENTS AND APOPROTEIN (a) PRODUCTION INHIBITORS
12/07/2005CN1705668A Heterocyclocarboxamide derivatives
12/07/2005CN1705659A Large conductance calcium-activated k channel opener
12/07/2005CN1704406A Intermediate for the preparation of epimino
12/07/2005CN1704400A Zinc pyrrolidonecarboxylate dihydrate and method of producing the same
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/06/2005US6972343 such as N,N'-diformyl-N,N'-di[1-methyl-2-S-thiobenzoyl-4-methoxybut-1-enyl]-1,12-diaminododecane; for treatment of malaria
12/06/2005US6972300 Compounds and compositions for delivering active agents
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005CA2268910C Asymmetrical imide bleach activators and compositions employing the same
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/06/2005CA2164832C Polyaspartic acid manufacture
1 ... 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 ... 404